tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Abivax moves lower after denying La Lettre report
PremiumThe FlyAbivax moves lower after denying La Lettre report
9d ago
Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca
Premium
The Fly
Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca
9d ago
AstraZeneca granted exclusive period by Abivax for buyout, La Lettre reports
Premium
The Fly
AstraZeneca granted exclusive period by Abivax for buyout, La Lettre reports
9d ago
Wedbush initiates Abivax with an Underperform, urges caution
PremiumThe FlyWedbush initiates Abivax with an Underperform, urges caution
25d ago
Abivax initiated with a Neutral at Wedbush
Premium
The Fly
Abivax initiated with a Neutral at Wedbush
25d ago
Obefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
Premium
Ratings
Obefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
26d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Abivax price target raised to $145 from $101 at Morgan Stanley
Premium
The Fly
Abivax price target raised to $145 from $101 at Morgan Stanley
2M ago
Abivax price target raised to $150 from $120 at BTIG
Premium
The Fly
Abivax price target raised to $150 from $120 at BTIG
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100